Analysis of melanomas for actionable mutations has become the standard of care. Recently, a classification scheme has been proposed that categorizes BRAF mutations based on their mechanisms for activation of the MAPK pathway. | Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing